**Core Concept**
The "Working Formulation" is a classification system for Non-Hodgkin Lymphoma (NHL) that categorizes the disease into distinct subtypes based on the type of lymphoid cells involved and their histological appearance. This system helps in understanding the disease's behavior and predicting patient outcomes.

**Why the Correct Answer is Right**
The Working Formulation was developed by a collaborative effort of pathologists and clinicians to standardize the classification of NHL. It recognizes four major categories: (1) small non-cleaved cell, (2) mixed cell, (3) lymphoblastic, and (4) follicular and diffuse lymphocytic, small cleaved-cell, and lymphocytic, well-differentiated. This classification system is still widely used today, especially in clinical practice and research.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the Working Formulation is not based on the International Classification of Diseases (ICD). While the ICD provides a standardized system for classifying diseases, the Working Formulation is a more specific classification system for NHL.
* **Option B:** This option is incorrect because the Rappaport classification is another system for classifying NHL, but it is not the basis for the Working Formulation.
* **Option C:** This option is incorrect because the Kiel classification is a system used for classifying lymphomas, but it is not directly related to the Working Formulation.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the Working Formulation is a historical classification system, and newer systems like the World Health Organization (WHO) classification have largely replaced it. However, understanding the Working Formulation can provide valuable insights into the evolution of NHL classification and diagnosis.

**Correct Answer:** D.